Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Sanofi (SNY) Invested Capital (2016 - 2025)

Sanofi's Invested Capital history spans 11 years, with the latest figure at $83.1 billion for Q4 2025.

  • For Q4 2025, Invested Capital fell 16.97% year-over-year to $83.1 billion; the TTM value through Dec 2025 reached $83.1 billion, down 16.97%, while the annual FY2025 figure was $80.6 billion, 20.44% down from the prior year.
  • Invested Capital for Q4 2025 was $83.1 billion at Sanofi, down from $100.1 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $100.1 billion in Q4 2024 and bottomed at $82.2 billion in Q4 2021.
  • The 5-year median for Invested Capital is $95.9 billion (2022), against an average of $91.7 billion.
  • The largest annual shift saw Invested Capital dropped 19.58% in 2021 before it grew 16.66% in 2022.
  • A 5-year view of Invested Capital shows it stood at $82.2 billion in 2021, then grew by 16.66% to $95.9 billion in 2022, then rose by 1.61% to $97.4 billion in 2023, then rose by 2.69% to $100.1 billion in 2024, then decreased by 16.97% to $83.1 billion in 2025.
  • Per Business Quant, the three most recent readings for SNY's Invested Capital are $83.1 billion (Q4 2025), $100.1 billion (Q4 2024), and $97.4 billion (Q4 2023).